Skip to content

Clinical trials

Terminated Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Terminated Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20171
20181
20193
20202
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Albert Einstein College of Medicine1
Ascentage Pharma Group Inc.1
Binhui Biopharmaceutical Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Chinese University of Hong Kong1
Henan Cancer Hospital1
Jiangsu HengRui Medicine Co., Ltd.1
Nerviano Medical Sciences1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai PerHum Therapeutics Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms13
Carcinoma, Ovarian Epithelial1
Sarcoma1
Stomach Neoplasms1
Urinary Bladder Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.